Lacrimal gland botulinum toxin injection for epiphora management

References

• Dalgleish R. Idiopathic acquired lacrimal drainage obstruction. Br J Ophthalmol. 1967;51(7):463–468. doi:https://doi.org/10.1136/bjo.51.7.463.
   PubMed Web of Science ®Google Scholar
• Shin J-H, Kim Y-D, Woo KI. Korean society of ophthalmic plastic and reconstructive Surgery (KSOPRS). Impact of epiphora on vision-related quality of life. BMC Ophthalmol. 2015;15:6. doi:https://doi.org/10.1186/1471-2415-15-6.
   PubMed Web of Science ®Google Scholar
• Chan W, Malhotra R, Kakizaki H, Leibovitch I, Selva D. Perspective: what does the term functional mean in the context of epiphora? Clin Exp Ophthalmol. 2012;40(7):749–754. doi:https://doi.org/10.1111/j.1442-9071.2012.02791.x.
   PubMed Web of Science ®Google Scholar
• Athanasiov PA, Madge S, Kakizaki H, Selva D. A review of bypass tubes for proximal lacrimal drainage obstruction. Surv Ophthalmol. 2011;56(3):252–266. doi:https://doi.org/10.1038/eye.2016.88.
   PubMed Web of Science ®Google Scholar
• Lim C, Martin P, Benger R, Kourt G, Ghabrial R. Lacrimal canalicular bypass surgery with the Lester Jones tube. Am J Ophthalmol. 2004;137(1):101–108. doi:https://doi.org/10.1016/j.ajo.2003.08.002.
   PubMed Web of Science ®Google Scholar
• Munk PL, Lin DT, Morris DC. Epiphora: treatment by means of dacryocystoplasty with balloon dilation of the nasolacrimal drainage apparatus. Radiology. 1990;177(3):687–690. doi:https://doi.org/10.1148/radiology.177.3.2243969.
   PubMed Web of Science ®Google Scholar
• Ullrich K, Malhotra R, Patel BC. Dacryocystorhinostomy. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2021 Jan. Accessed February 14, 2021. http://www.ncbi.nlm.nih.gov/books/NBK557851/.
   Google Scholar
• Trimarchi M, Giordano Resti A, Vinciguerra A, Danè G, Bussi M. Dacryocystorhinostomy: evolution of endoscopic techniques after 498 cases. Eur J Ophthalmol. 2020;30(5):998–1003. doi:https://doi.org/10.1177/1120672119854582.
   PubMed Web of Science ®Google Scholar
• Yang J, Cao Z, Gu Z. Modified endoscopic dacryocystorhinostomy using the middle uncinate process approach. J Craniofac Surg. 2020;31(5):1464–1466. doi:https://doi.org/10.1097/SCS.0000000000006493.
   PubMed Web of Science ®Google Scholar
• Eisenbach N, Karni O, Sela E, Nemet A, Dror A, Levy E, Kassif Y, Ovadya R, Ronen O, Marshak T. Conjunctivodacryocystorhinostomy (CDCR) success rates and complications in endoscopic vs non-endoscopic approaches: a systematic review. Int Forum Allergy Rhinol. August 6, 2020. Published online. doi:https://doi.org/10.1002/alr.22668.
   PubMed Web of Science ®Google Scholar
• Woog JJ, Sindwani R. Endoscopic dacryocystorhinostomy and conjunctivodacryocystorhinostomy. Otolaryngol Clin North Am. 2006;39(5):1001–1017. doi:https://doi.org/10.1016/j.otc.2006.08.005.
   PubMed Web of Science ®Google Scholar
• Hornblass A, Guberina C, Herschorn BJ. Palpebral dacryoadenectomy for epiphora. Ophthal Plast Reconstr Surg. 1988;4(4):227–230. doi:https://doi.org/10.1097/00002341-198804040-00005.
   PubMedGoogle Scholar
• Woog JJ. The incidence of symptomatic acquired lacrimal outflow obstruction among residents of Olmsted County, Minnesota, 1976-2000 (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc. 2007;105:649–666.
   PubMedGoogle Scholar
• MacEwen CJ, Young JD. Epiphora during the first year of life. Eye Lond Engl. 1991;5(Pt 5):596–600. doi:https://doi.org/10.1038/eye.1991.103.
   PubMedGoogle Scholar
• van Ermengem E. Classics in infectious diseases. A new anaerobic bacillus and its relation to botulism. E. van Ermengem. Originally published as “Ueber einen neuen anaëroben Bacillus und seine Beziehungen zum Botulismus” in Zeitschrift für Hygiene und Infektionskrankheiten 26: 1-56, 1897. Rev Infect Dis. 1979;1:701–719.
   PubMedGoogle Scholar
• Erbguth FJ. Historical notes on botulism, Clostridium botulinum, botulinum toxin, and the idea of the therapeutic use of the toxin. Mov Disord Off J Mov Disord Soc. 2004;19(Suppl 8):S2–6. doi:https://doi.org/10.1002/mds.20003.
   PubMed Web of Science ®Google Scholar
• Melling J, Hambleton P, Shone CC. Clostridium botulinum toxins: nature and preparation for clinical use. Eye. 1988;2(1):16–23. doi:https://doi.org/10.1038/eye.1988.5.
   PubMed Web of Science ®Google Scholar
• Scott AB, Rosenbaum A, Collins CC. Pharmacologic weakening of extraocular muscles. Invest Ophthalmol. 1973;12:924–927.
   PubMedGoogle Scholar
• Dong M, Masuyer G, Stenmark P. Botulinum and tetanus neurotoxins. Annu Rev Biochem. 2019;88:811–837. doi:https://doi.org/10.1146/annurev-biochem-013118-111654.
   PubMed Web of Science ®Google Scholar
• Frueh BR, Felt DP, Wojno TH, Musch DC. Treatment of blepharospasm with botulinum toxin. A preliminary report. Arch Ophthalmol Chic Il 1960. 1984;102(10):1464–1468. doi:https://doi.org/10.1001/archopht.1984.01040031184014.
   PubMedGoogle Scholar
• Whittaker KW, Matthews BN, Fitt AW, Sandramouli S. The use of botulinum toxin A in the treatment of functional epiphora. Orbit. 2003;22(3):193–198. doi:https://doi.org/10.1076/orbi.22.3.193.15622.
   PubMedGoogle Scholar
• Wojno TH. Results of lacrimal gland botulinum toxin injection for epiphora in lacrimal obstruction and gustatory tearing. Ophthal Plast Reconstr Surg. 2011;27(2):119–121. doi:https://doi.org/10.1097/IOP.0b013e318201d1d3.
   PubMed Web of Science ®Google Scholar
• Girard B, Piaton J-M, Keller P, Nguyen TH. Botulinum neurotoxin A injection for the treatment of epiphora with patent lacrymal ducts. J Fr Ophtalmol. 2018;41(4):343–349. doi:https://doi.org/10.1016/j.jfo.2017.11.010.
   PubMed Web of Science ®Google Scholar
• Shan XF, Lv L, Cai Z-G, Yu G-Y. Botulinum toxin A treatment of epiphora secondary to autologous submandibular gland transplantation. Int J Oral Maxillofac Surg. 2019;48(4):475–479. doi:https://doi.org/10.1016/j.ijom.2018.07.003.
   PubMed Web of Science ®Google Scholar
• Keegan DJ, Geerling G, Lee JP, Blake G, Collin JR, Plant GT. Botulinum toxin treatment for hyperlacrimation secondary to aberrant regenerated seventh nerve palsy or salivary gland transplantation. Br J Ophthalmol. 2002;86(1):43–46. doi:https://doi.org/10.1136/bjo.86.1.43.
   PubMed Web of Science ®Google Scholar
• Nava-Castañeda A, Tovilla-Canales JL, Boullosa V, Tovilla-y-Pomar JL, Monroy-Serrano MH, Tapia-Guerra V, et al. Duration of botulinum toxin effect in the treatment of crocodile tears. Ophthal Plast Reconstr Surg. 2006;22(6):453–456. doi:https://doi.org/10.1097/01.iop.0000244515.07925.99.
   PubMed Web of Science ®Google Scholar
• Hofmann RJ. Treatment of Frey’s syndrome (gustatory sweating) and “crocodile tears” (gustatory epiphora) with purified botulinum toxin. Ophthal Plast Reconstr Surg. 2000;16(4):289–291. doi:https://doi.org/10.1097/00002341-200007000-00007.
   PubMed Web of Science ®Google Scholar
• Montoya FJ, Riddell CE, Caesar R, Hague S. Treatment of gustatory hyperlacrimation (crocodile tears) with injection of botulinum toxin into the lacrimal gland. Eye. 2002;16(6):705–709. doi:https://doi.org/10.1038/sj.eye.6700230.
   PubMed Web of Science ®Google Scholar
• Girard B, Piaton J-M, Keller P, Abadie C, Nguyen TH. Botulinum neurotoxin injection for the treatment of epiphora in nasolacrimal duct obstruction. J Fr Ophtalmol. 2017;40(8):661–665. doi:https://doi.org/10.1016/j.jfo.2017.03.006.
   PubMed Web of Science ®Google Scholar
• Ziahosseini K, Al-Abbadi Z, Malhotra R. Botulinum toxin injection for the treatment of epiphora in lacrimal outflow obstruction. Eye. 2015;29(5):656–661. doi:https://doi.org/10.1038/eye.2015.18.
   PubMed Web of Science ®Google Scholar
• Kaynak P, Karabulut GO, Ozturker C, Fazil K, Arat YO, Perente I, et al. Comparison of botulinum toxin-A injection in lacrimal gland and conjunctivodacryocystorhinostomy for treatment of epiphora due to proximal lacrimal system obstruction. Eye. 2016;30(8):1056–1062. doi:https://doi.org/10.1038/eye.2016.88.
   PubMed Web of Science ®Google Scholar
• Eustis HS, Babiuch A. Botulinum toxin injection into the lacrimal gland for treatment of proximal nasolacrimal duct obstructions in children. J Pediatr Ophthalmol Strabismus. 2014;51 Online:e75–77. doi:https://doi.org/10.3928/01913913-20141120-02.
   PubMed Web of Science ®Google Scholar
• Ahn C, Kang S, Sa H-S. Repeated injections of botulinum toxin-A for epiphora in lacrimal drainage disorders: qualitative and quantitative assessment. Eye Lond Engl. 2019;33(6):995–999. doi:https://doi.org/10.1038/s41433-019-0362-x.
   PubMed Web of Science ®Google Scholar
• Singh S, Nair A, Alam M, Mukherjee B. Outcomes of lacrimal gland injection of botulinum toxin in functional versus nonfunctional epiphora. Oman J Ophthalmol. 2019;12(2):104. doi:https://doi.org/10.4103/ojo.OJO_52_2018.
   PubMedGoogle Scholar
• Lee AG, Lee S-H, Jang M, Lee SJ, Shin HJ. Transconjunctival versus transcutaneous injection of botulinum toxin into the lacrimal gland to reduce lacrimal production: a randomized controlled trial. Toxins (Basel). 2021;13:2. doi:https://doi.org/10.3390/toxins13020077.
   Web of Science ®Google Scholar
• Bakri SJ, Carney AS, Robinson K, Jones NS, Downes RN. Quality of life outcomes following dacryocystorhinostomy: external and endonasal laser techniques compared. Orbit Amst Neth. 1999;18(2):83–88. doi:https://doi.org/10.1076/orbi.18.2.83.2720.
   PubMedGoogle Scholar
• Kafil-Hussain N, Khooshebah R. Clinical research, comparison of the subjective visual function in patients with epiphora and patients with second-eye cataract. Orbit. 2005;24(1):33–38. doi:https://doi.org/10.1080/01676830590897155.
   PubMedGoogle Scholar
• Falzon K, Galea M, Cunniffe G, Logan P. Transconjunctival botulinum toxin offers an effective, safe and repeatable method to treat gustatory lacrimation. Br J Ophthalmol. 2010;94(3):379–380. doi:https://doi.org/10.1136/bjo.2008.155887.
   PubMed Web of Science ®Google Scholar
• Chang C-H, Chen Y-C, Lee C-L, Chu S-W. Application of the Metaireau tube (M-tube) in conjunctivodacryocystorhinostomy (CDCR). Taiwan J Ophthalmol. 2013;3(2):71–74. doi:https://doi.org/10.1016/j.tjo.2013.04.002.
   Google Scholar
• Jones LT. CONJUNCTIVODACRYOCYSTORHINOSTOMY. Am J Ophthalmol. 1965;59:773–783. doi:https://doi.org/10.1016/0002-9394(65)93004-7.
   PubMed Web of Science ®Google Scholar
• Devoto MH, Bernardini FP, de Conciliis C. Minimally invasive conjunctivodacryocystorhinostomy with Jones tube. Ophthal Plast Reconstr Surg. 2006;22(4):253–255. doi:https://doi.org/10.1097/01.iop.0000226861.02781.af.
   PubMed Web of Science ®Google Scholar
• Steele EA, Dailey RA. Conjunctivodacryocystorhinostomy with the frosted jones pyrex tube. Ophthal Plast Reconstr Surg. 2009;25(1):42–43. doi:https://doi.org/10.1097/IOP.0b013e3181911d13.
   PubMed Web of Science ®Google Scholar
• Eleopra R, Rinaldo S, Montecucco C, Rossetto O, Devigili G. Clinical duration of action of different botulinum toxin types in humans. Toxicon. 2020;179:84–91. doi:https://doi.org/10.1016/j.toxicon.2020.02.020.
   PubMed Web of Science ®Google Scholar
• Kranz G, Paul A, Voller B, Posch M, Windischberger C, Auff E, et al. Long-term efficacy and respective potencies of botulinum toxin A and B: a randomized, double-blind study: respective potencies of botulinum toxin A and B. Br J Dermatol. 2011;164(1):176–181. doi:https://doi.org/10.1111/j.1365-2133.2010.10085.x.
   PubMed Web of Science ®Google Scholar
• Heckmann M. Low-dose efficacy of botulinum toxin a for axillary hyperhidrosis: a randomized, side-by-side, open-label study. Arch Dermatol. 2005;141(10):1255. doi:https://doi.org/10.1001/archderm.141.10.1255.
   PubMedGoogle Scholar
• Vadoud-Seyedi J, Simonart T. Treatment of axillary hyperhidrosis with botulinum toxin type A reconstituted in lidocaine or in normal saline: a randomized, side-by-side, double-blind study. Br J Dermatol. 2007;156(5):986–989. doi:https://doi.org/10.1111/j.1365-2133.2007.07760.x.
   PubMed Web of Science ®Google Scholar
• Naumann M, Lowe NJ. Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, placebo controlled. BMJ. 2001;323(7313):. 596-596 doi:https://doi.org/10.1136/bmj.323.7313.596.
   PubMed Web of Science ®Google Scholar
• Anari S, Ainsworth G, Robson AK. Cost-efficiency of endoscopic and external dacryocystorhinostomy. J Laryngol Otol. 2008;122(5):476–479. doi:https://doi.org/10.1017/S0022215107009954.
   PubMed Web of Science ®Google Scholar
• University of Illinois Health. Billing and pricing. https://hospital.uillinois.edu/patients-and-visitors/patient-information/billing-and-pricing. Published online 2021. Accessed July 5, 2021.
   Google Scholar
• Allergan Inc. Allergan pricing: botox. AbbVie. https://www.allerganpricing.com/botox?guid=BTXCM_DTC_Pricing. Published online July 2021. Accessed July 5, 2021.
   Google Scholar